Literature DB >> 6777178

Efficacy and tolerance of tocainide during acute and long-term treatment of chronic ventricular arrhythmias.

C Sonnhag.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6777178     DOI: 10.1007/bf00561386

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  18 in total

1.  Suppression of ventricular ectopic depolarizations by tocainide.

Authors:  R L Woosley; D G McDevitt; A S Nies; R F Smith; G R Wilkinson; J A Oates
Journal:  Circulation       Date:  1977-12       Impact factor: 29.690

2.  Response optimization of drug dosage: antiarrhythmic studies with tocainide.

Authors:  P J Meffin; R A Winkle; T F Blaschke; J Fitzgerald; D C Harrison; S R Harapat; P A Bell
Journal:  Clin Pharmacol Ther       Date:  1977-07       Impact factor: 6.875

3.  Prognostic significance of ventricular ectopic beats with respect to sudden death in the late postinfarction period.

Authors:  M N Kotler; B Tabatznik; M M Mower; S Tominaga
Journal:  Circulation       Date:  1973-05       Impact factor: 29.690

4.  Procainamide dosage schedules, plasma concentrations, and clinical effects.

Authors:  J Koch-Weser; S W Klein
Journal:  JAMA       Date:  1971-03-01       Impact factor: 56.272

5.  The frequency of asymptomatic disturbances of cardiac rhythm and conduction in middle-aged men.

Authors:  L E Hinkle; S T Carver; M Stevens
Journal:  Am J Cardiol       Date:  1969-11       Impact factor: 2.778

6.  Comparative antiarrhythmic efficacy of intravenous N-acetylprocainamide and procainamide.

Authors:  C Sonnhag; E Karlsson
Journal:  Eur J Clin Pharmacol       Date:  1979-06-12       Impact factor: 2.953

7.  Prognostic implications of ventricular arrhythmias registered before discharge and one year after acute myocardial infarction.

Authors:  N Rehnqvist; T Lundman; A Sjögren
Journal:  Acta Med Scand       Date:  1978

8.  Comparative evaluation of intravenous phenytoin, procainamide and practolol in the acute treatment of ventricular arrhythmias.

Authors:  E Karlsson; A Kinman; C Sonnhag
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

9.  Antiarrhythmic drug effect assessed from ventricular arrhythmia reduction in the ambulatory electrocardiogram and treadmill test: comparison of propranolol, procainamide and quinidine.

Authors:  R A Winkle; A H Gradman; J W Fitzgerald
Journal:  Am J Cardiol       Date:  1978-09       Impact factor: 2.778

10.  Long-term tocainide therapy for ventricular arrhythmias.

Authors:  R A Winkle; P J Meffin; D C Harrison
Journal:  Circulation       Date:  1978-05       Impact factor: 29.690

View more
  3 in total

Review 1.  Serum tocainide enantiomer concentrations in human subjects.

Authors:  A J Sedman; J Gal; W Mastropaolo; P Johnson; J D Maloney; T P Moyer
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

Review 2.  Tocainide. A review of its pharmacological properties and therapeutic efficacy.

Authors:  B Holmes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-08       Impact factor: 9.546

Review 3.  New antiarrhythmic drugs.

Authors:  P F Nestico; J Morganroth; L N Horowitz
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.